Study guide

Radiation Therapy Principles, Toxicities, and Teaching

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

Radiation Therapy Principles, Toxicities, and Teaching

Key Takeaways Explain This Topic AI

Ionizing radiation damages DNA; effects are local to the treatment field, dose-dependent, and split into acute (during/weeks) and late (months-years) toxicities.

External beam delivers fractionated dose (commonly 1.8-2 Gy/fraction); SBRT/SRS uses few high-dose fractions; brachytherapy and radiopharmaceuticals add radiation-safety precautions.

External beam patients are NOT radioactive; sealed-source brachytherapy requires time-distance-shielding, and a dislodged source is a radiation emergency handled with long forceps, never bare hands.

Skin reactions are graded; moist desquamation and confluent reactions need wound care, and patients must not apply unapproved products or remove skin marks.

Site-specific toxicities (mucositis, esophagitis, pneumonitis, cystitis, proctitis) and concurrent chemoradiation intensify risk and may force treatment breaks.

Last updated: June 2026

Radiation Therapy Principles, Toxicities, and Teaching

Radiation therapy treats cancer by delivering ionizing radiation that damages cellular DNA, killing dividing cells while sparing adjacent normal tissue through precise targeting. Dose is measured in gray (Gy) and usually divided into daily fractions (commonly 1.8-2 Gy each, over several weeks) - fractionation lets normal tissue repair between treatments. Radiation may be curative, adjuvant, neoadjuvant, consolidative, prophylactic (for example prophylactic cranial irradiation in small cell lung cancer), or palliative.

The OCN RN assesses, educates, manages symptoms, coordinates, and recognizes emergencies; the RN does not prescribe dose or design the field.

How radiation is delivered

Method Description Nursing implication

External beam radiation therapy (EBRT) Beam from a linear accelerator outside the body Daily visits, skin care, fatigue; patient is NOT radioactive

Stereotactic (SBRT body / SRS brain) Highly focused, few high-dose fractions Precise immobilization, focal symptom reporting

Brachytherapy Sealed radioactive source placed in/near tumor Time, distance, shielding while source is in place

Radiopharmaceutical (e.g., radioactive iodine, radium-223) Systemic radioactive agent targets tissue Excretion precautions, hydration, contamination teaching

Simulation is the planning visit: immobilization devices (head/neck masks), skin tattoos or marks, planning CT, possible contrast, and bladder/bowel prep. Reinforce that simulation is usually not treatment. Daily EBRT is painless and brief; setup often takes longer than beam-on time. Patients should not scrub off marks and should report fading.

Acute vs late toxicities and skin grading

Effects depend on site, total dose, fractionation, combined therapy, and patient factors. Acute effects appear during or within weeks; late effects (fibrosis, strictures, secondary malignancy, lymphedema) appear months to years later and may be permanent. Fatigue is nearly universal and can be disproportionate to visible change. Radiation dermatitis progresses through stages roughly aligned with grading:

  • Grade Skin finding Nursing action
  • 1 Faint erythema, dry desquamation Gentle cleansing, mild moisturizer, sun protection
  • 2 Bright erythema, patchy moist desquamation, edema Non-adherent dressings, monitor for infection
  • 3 Confluent moist desquamation, bleeding with trauma Wound care referral, pain control
  • 4 Skin necrosis, full-thickness ulceration Urgent provider/wound evaluation

Teach gentle cleansing, no friction, protection from sun and temperature extremes, loose clothing, and no products in the field unless the radiation team approves (avoid metallic ointments before treatment).

Site-specific toxicities

Head and neck: mucositis, xerostomia, taste changes, dysphagia, thick secretions, dental complications, aspiration and weight loss - dental clearance before therapy is standard.

Thoracic: esophagitis, cough, and radiation pneumonitis (dry cough, dyspnea, low-grade fever 1-3 months after); cardiac dose concerns.

Breast/chest wall: skin changes, fatigue, later fibrosis and lymphedema risk.

Abdomen/pelvis: nausea, diarrhea, cystitis , proctitis , sexual and fertility effects, and marrow suppression if large marrow-bearing fields are treated.

Brain: fatigue, in-field alopecia, headache, nausea, cognitive change, and cerebral edema symptoms.

Urgent findings and concurrent therapy

Patients must know when to call: fever, uncontrolled vomiting or diarrhea, dehydration, inability to swallow fluids, bleeding, severe pain, dyspnea, chest pain, confusion, or rapidly worsening skin breakdown. With brain or spine radiation, new weakness, bowel/bladder change, severe headache, seizure, or mental status change is urgent. Concurrent chemoradiation intensifies mucositis, dermatitis, cytopenias, and esophagitis; immunotherapy near thoracic radiation can blur pneumonitis evaluation.

Radiation safety: the load-bearing rule

EBRT patients are not radioactive - stating this reduces needless fear. For a hospitalized patient with a temporary sealed source , follow time (minimize), distance (maximize), and shielding , wear a dosimeter, and limit visitor and staff time. A dislodged source is a radiation emergency : never touch it bare-handed - use long-handled forceps, place it in the lead container, secure the room, and notify radiation safety per policy.

For radiopharmaceuticals (such as radioactive iodine, or radium-223 for bone metastases), teach hydration, separate toilet use with double flushing, careful body-fluid handling, separate laundering, and distance from pregnant people and small children for the ordered period.

Managing the most common toxicities

Fatigue is managed with planned rest, light activity, and energy conservation - and with correction of contributing anemia, dehydration, or poor intake. For oral mucositis during head and neck radiation, teach a bland-rinse regimen (salt-and-soda or saline rinses several times daily), soft moist foods, alcohol-free mouth care, and avoidance of tobacco, alcohol, and spicy or acidic foods; magic-mouthwash and systemic analgesia are added per order, and candidal superinfection is treated. For radiation-induced nausea (upper abdomen, large fields, or total body irradiation) antiemetics are given before treatment.

Diarrhea from pelvic radiation is managed with a low-residue diet, hydration, and antidiarrheals per plan, while watching for dehydration that can interrupt treatment.

Patient support and documentation

Radiation schedules are demanding - daily visits over several weeks strain transportation, work, and caregiving. The nurse connects patients with dietitians, social work, dental oncology, speech therapy, wound care, and palliative care, and reinforces smoking cessation because tobacco worsens mucositis and reduces tumor oxygenation and treatment effect. Document treatment site, fraction timing, toxicity grade, intake and weight trends, vital signs, skin and mucosal findings, interventions, education, and communication with radiation oncology - small problems caught early prevent treatment interruptions that compromise the curative dose.